Eastwood Bio-Medical Canada, Inc. (EBM.V)
1.89
-0.05
(-2.58%)
CAD |
TSXV |
Oct 13, 16:00
Eastwood Bio-Medical Canada Profit Margin (Quarterly) : -45.13% for July 31, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -45.13% |
| April 30, 2026 | -45.79% |
| January 31, 2026 | -13.60% |
| October 31, 2025 | -21.06% |
| July 31, 2025 | -46.06% |
| April 30, 2025 | -204.3% |
| January 31, 2025 | -19.19% |
| October 31, 2024 | -87.78% |
| July 31, 2024 | -61.18% |
| April 30, 2024 | -96.23% |
| January 31, 2024 | -26.97% |
| October 31, 2023 | -142.7% |
| July 31, 2023 | -62.73% |
| April 30, 2023 | -80.02% |
| January 31, 2023 | -20.83% |
| October 31, 2022 | -6.56% |
| July 31, 2022 | -29.91% |
| April 30, 2022 | -9.68% |
| January 31, 2022 | -3.11% |
| October 31, 2021 | -1.99% |
| Date | Value |
|---|---|
| July 31, 2021 | -78.24% |
| April 30, 2021 | -80.62% |
| January 31, 2021 | -96.18% |
| October 31, 2020 | -136.1% |
| July 31, 2020 | -39.70% |
| April 30, 2020 | -133.7% |
| January 31, 2020 | -178.3% |
| October 31, 2019 | -66.33% |
| July 31, 2019 | -50.28% |
| April 30, 2019 | -91.59% |
| January 31, 2019 | 1.06% |
| October 31, 2018 | -80.85% |
| July 31, 2018 | -98.72% |
| April 30, 2018 | -293.3% |
| January 31, 2018 | -165.2% |
| October 31, 2017 | -140.5% |
| July 31, 2017 | -104.4% |
| April 30, 2017 | -72.30% |
| January 31, 2017 | -110.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -95.78% |
| Gross Profit Margin (Quarterly) | 47.66% |
| Operating Margin (Quarterly) | -44.19% |
| Return on Net Operating Assets | -101.7% |